Tim F Greten

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 61

Top Topics

Metastatic Colorectal Cancer

Immune Response

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

Nature reviews. Gastroenterology & hepatology

Nature reviews. Cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F Greten, Bin Gao
Alcohol-associated liver cancer. Hepatology (Baltimore, Md.) (2024)
Kylynda C Bauer, Rajiv Trehan, Benjamin Ruf, Yuta Myojin, Mohamed-Reda Benmebarek, Chi Ma, Matthias Seifert, Amran Nur, Jonathan Qi, Patrick Huang, Marlaine Soliman, Benjamin L Green, Simon Wabitsch, Danielle A Springer, Francisco J Rodriguez-Matos, Shadin Ghabra, Stephanie N Gregory, Jennifer Matta, Brian Dawson, Jihye L Golino, Changqing Xie, Amiran K Dzutsev, Giorgio Trinchieri, Firouzeh Korangy, Tim F Greten
The Gut Microbiome Controls Liver Tumors via the Vagus Nerve. bioRxiv : the preprint server for biology (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Benjamin Ruf, Tim F Greten, Firouzeh Korangy
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nature reviews. Cancer (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine 13 (1) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Benjamin Ruf, Tim F Greten, Firouzeh Korangy
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nature reviews. Cancer (2023)
Benjamin Ruf, Tim F Greten, Firouzeh Korangy
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nature reviews. Cancer (2023)
Chi Ma, Justin McCallen, John C McVey, Rajiv Trehan, Kylynda Bauer, Qianfei Zhang, Benjamin Ruf, Sophie Wang, Chunwei Walter Lai, Giorgio Trinchieri, David M Moore, Firouzeh Korangy, Tim F Greten
CSF-1R+ Macrophages Control the Gut Microbiome-enhanced Liver Invariant NKT Function through IL-18. Journal of immunology (Baltimore, Md. : 1950) (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Benjamin L Green, Yuta Myojin, Chi Ma, Benjamin Ruf, Lichun Ma, Qianfei Zhang, Umberto Rosato, Jonathan Qi, Mahler Revsine, Simon Wabitsch, Kylynda Bauer, Mohamed-Reda Benmebarek, Justin McCallen, Amran Nur, Xin Wang, Vivek Sehra, Revant Gupta, Manfred Claassen, Xin Wei Wang, Firouzeh Korangy, Tim F Greten
Immunosuppressive CD29 + Treg accumulation in the liver in mice on checkpoint inhibitor therapy. Gut (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Josep M Llovet, Catherine E Willoughby, Amit G Singal, Tim F Greten, Mathias Heikenwälder, Hashem E El-Serag, Richard S Finn, Scott L Friedman
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nature reviews. Gastroenterology & hepatology (2023)
Tim F Greten, Augusto Villanueva, Firouzeh Korangy, Benjamin Ruf, Mark Yarchoan, Lichun Ma, Eytan Ruppin, Xin W Wang
Biomarkers for immunotherapy of hepatocellular carcinoma. Nature reviews. Clinical oncology (2023)
Benjamin Ruf, Tim F Greten, Firouzeh Korangy
Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nature reviews. Cancer (2023)
Cecilia Monge Bonilla, J Alberto Maldonado, Katherine A McGlynn, Tim F Greten
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States. Journal of hepatocellular carcinoma 10 (2023)
Tim F Greten, Robert F Schwabe, Nabeel El-Bardeesy, Lichun Ma, Lipika Goyal, Robin Kate Kelley, Xin W Wang
Immunology and immunotherapy of cholangiocarcinoma. Nature reviews. Gastroenterology & hepatology (2023)
Tim F Greten
'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCC. Gut (2023)
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Cecilia Monge Bonilla, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William Douglas Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The oncologist 27 (3) (2022)
Tim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, Austin G Duffy, Anthony B El-Khoueiry, Richard S Finn, Peter R Galle, Lipika Goyal, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Amaia Lujambio, Donna Mabry Hrones, David James Pinato, Bruno Sangro, Roberto I Troisi, Andrea Wilson Woods, Thomas Yau, Andrew X Zhu, Ignacio Melero Bermejo
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma. Journal for immunotherapy of cancer 9 (9) (2022)
Michael B Atkins, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Michael R Bishop, Daniel C Chen, Madhav Dhodapkar, Leisha A Emens, Marc S Ernstoff, Matthew J Ferris, Tim F Greten, James L Gulley, Roy S Herbst, Rachel W Humphrey, James Larkin, Kim A Margolin, Luca Mazzarella, Suresh S Ramalingam, Meredith M Regan, Brian I Rini, Mario Sznol
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC). Journal for immunotherapy of cancer 10 (9) (2022)
Lichun Ma, Sophia Heinrich, Limin Wang, Friederike L Keggenhoff, Subreen Khatib, Marshonna Forgues, Michael C Kelly, Stephen M Hewitt, Areeba Saif, Jonathan M Hernandez, Donna Mabry, Roman Klöckner, Tim F Greten, Jittiporn Chaisaingmongkol, Mathuros Ruchirawat, Jens-Uwe Marquardt, Xin Wei Wang
Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer. Nature communications 13 (1) (2022)
Bernd Heinrich, E Michael Gertz, Alejandro A Schäffer, Amanda Craig, Benjamin Ruf, Varun Subramanyam, John C McVey, Laurence P Diggs, Sophia Heinrich, Umberto Rosato, Chi Ma, Chunhua Yan, Ying Hu, Yongmei Zhao, Tsai-Wei Shen, Veena Kapoor, William Telford, David E Kleiner, Merril K Stovroff, Harmeet S Dhani, Jiman Kang, Thomas Fishbein, Xin Wei Wang, E Ruppin, Alexander Kroemer, Tim F Greten, Firouzeh Korangy
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma. Gut (2021)
Benjamin Ruf, Vanessa V Catania, Simon Wabitsch, Chi Ma, Laurence P Diggs, Qianfei Zhang, Bernd Heinrich, Varun Subramanyam, Linda L Cui, Marie Pouzolles, Christine N Evans, Raj Chari, Shunsuke Sakai, Sangmi Oh, Clifton Earl Barry, Daniel L Barber, Tim F Greten
Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response. Cancer immunology research 9 (9) (2021)
Man Hsin Hung, Joo Sang Lee, Chi Ma, Laurence P Diggs, Sophia Heinrich, Ching Wen Chang, Lichun Ma, Marshonna Forgues, Anuradha Budhu, Jittiporn Chaisaingmongkol, Mathuros Ruchirawat, Eytan Ruppin, Tim F Greten, Xin Wei Wang
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma. Nature communications 12 (1) (2021)
Robin Kate Kelley, Tim F Greten
Hepatocellular Carcinoma - Origins and Outcomes. The New England journal of medicine 385 (3) (2021)
Josep M Llovet, Thierry De Baere, Laura Kulik, Philipp K Haber, Tim F Greten, Tim Meyer, Riccardo Lencioni
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology 18 (5) (2021)
Gagandeep Brar, Tim F Greten, Barry I Graubard, Timothy S McNeel, Jessica L Petrick, Katherine A McGlynn, Sean F Altekruse
Hepatocellular Carcinoma Survival by Etiology: A SEER-Medicare Database Analysis. Hepatology communications 4 (10) (2020)
Su Jong Yu, Tim F Greten
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of liver cancer 20 (1) (2020)
Su Jong Yu, Tim F Greten
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of liver cancer 20 (1) (2020)
Su Jong Yu, Tim F Greten
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of liver cancer 20 (1) (2020)
Changqing Xie, Austin G Duffy, Gagandeep Brar, Suzanne Fioravanti, Donna Mabry-Hrones, Melissa Walker, Cecilia Monge Bonilla, Bradford J Wood, Deborah E Citrin, Elizabeth M Gil Ramirez, Freddy E Escorcia, Bernadette Redd, Jonathan M Hernandez, Jeremy L Davis, Billel Gasmi, David E Kleiner, Seth M Steinberg, Jennifer C Jones, Tim F Greten
Immune Checkpoint Blockade in Combination with Stereotactic Body Radiotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (10) (2020)
Su Jong Yu, Tim F Greten
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma. Journal of liver cancer 20 (1) (2020)
Josep M Llovet, Augusto Villanueva, Jorge A Marrero, Myron Schwartz, Tim Meyer, Peter R Galle, Riccardo Lencioni, Tim F Greten, Masatoshi Kudo, Sumithra J Mandrekar, Andrew X Zhu, Richard S Finn, Lewis Rowland Roberts, null null
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference. Hepatology (Baltimore, Md.) (2020)
Benjamin Ruf, Bernd Heinrich, Tim F Greten
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells. Cellular & molecular immunology 18 (1) (2020)
Qianfei Zhang, Chi Ma, Yi Duan, Bernd Heinrich, Umberto Rosato, Laurence P Diggs, Soumen Roy, Qiong Fu, Zachary J Brown, Simon Wabitsch, Vishal Thovarai, Jianyang Fu, Dechun Feng, Benjamin Ruf, Linda L Cui, Varun Subramanyam, Karen M Frank, Xin Wei Wang, David E Kleiner, Thomas Ritz, Christian Rupp, Bin Gao, Thomas Longerich, Alexander Kroemer, Mathuros Ruchirawat, Firouzeh Korangy, Bernd Schnabl, Giorgio Trinchieri, Tim F Greten
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma. Cancer discovery 11 (5) (2020)
David Agdashian, Mei ElGindi, Changqing Xie, Milan Sandhu, Drew Pratt, David E Kleiner, William D Figg, Julie A Rytlewski, Catherine Sanders, Erik C Yusko, Bradford Wood, David Venzon, Gagandeep Brar, Austin G Duffy, Tim F Greten, Firouzeh Korangy
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 68 (4) (2019)
Laurence P Diggs, Tim F Greten
The effects of platelet accumulation in fatty liver disease. Nature reviews. Gastroenterology & hepatology 16 (7) (2019)
Zachary J Brown, Bernd Heinrich, Tim F Greten
Mouse models of hepatocellular carcinoma: an overview and highlights for immunotherapy research. Nature reviews. Gastroenterology & hepatology 15 (9) (2019)
Zachary J Brown, Su Jong Yu, Bernd Heinrich, Chi Ma, Qiong Fu, Milan Sandhu, David Agdashian, Qianfei Zhang, Firouzeh Korangy, Tim F Greten
Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer immunology, immunotherapy : CII 67 (8) (2018)
Hiroki Ishii, Suman K Vodnala, Bhagelu R Achyut, Jae Young So, M Christine Hollander, Tim F Greten, Ashish Lal, Li Yang
miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity. Nature communications 9 (1) (2018)
Zachary J Brown, Qiong Fu, Chi Ma, Michael Kruhlak, Haibo Zhang, Ji Luo, Bernd Heinrich, Su Jong Yu, Qianfei Zhang, Andrew Wilson, Zhen-Dan Shi, Rolf Swenson, Tim F Greten
Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development. Cell death & disease 9 (6) (2018)
Chi Ma, Miaojun Han, Bernd Heinrich, Qiong Fu, Qianfei Zhang, Milan Sandhu, David Agdashian, Masaki Terabe, David M Moore, Valerie Fako, Thomas Ritz, Thomas Longerich, Casey M Theriot, John A McCulloch, Soumen Roy, Wuxing Yuan, Vishal Thovarai, Shurjo K Sen, Mathuros Ruchirawat, Firouzeh Korangy, Xin Wei Wang, Giorgio Trinchieri, Tim F Greten
Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science (New York, N.Y.) 360 (6391) (2018)
Dung T Le, Jennifer N Durham, Kellie N Smit, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber, Fay Wong, Nilofer S Azad, Agnieszka A Rucki, Dan Laheru, Ross Donehower, Atif Zaheer, George A Fisher, Todd S Crocenzi, James J Lee, Tim F Greten, Austin G Duffy, Kristen K Ciombor, Aleksandra D Eyring, Bao H Lam, Andrew Joe, S Peter Kang, Matthias Holdhoff, Ludmila V Danilova, Leslie Cope, Christian F Meyer, Shibin Zhou, Richard M Goldberg, Deborah K Armstrong, Katherine M Bever, Amanda N Fader, Janis Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M Pardoll, Nickolas Papadopoulos, Kenneth W Kinzler, James R Eshleman, Bert Vogelstein, Robert A Anders, Luis A Diaz
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science (New York, N.Y.) 357 (6349) (2017)